VANCOUVER, BC, Oct. 7, 2021 VANCOUVER, BC , Oct. 7, 2021 /CNW/ – HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) is pleased to ...
NEW YORK , Oct. 7, 2021 /PRNewswire/ — BRIGHT MINDS BIOSCIENCES INC. (CSE: DRUG/OTCIQ: BMBIF), based in New York focused on new approaches to neuroscience, today announced that Ian McDonald , President & CEO and Josh ...
Silo Pharma, Inc. (OTCQB: SILO) a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced that their joint venture partner ...
KCSA Psychedelics Investor Conference to be held at VirtualInvestorConferences.com on October 13-14, 2021. Mr. Rands will discuss Small Pharma’s progress in the development of N,N-dimethyltryptamine ...
San Diego, California–(Newsfile Corp. – October 7, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (” Tryp ” or the ” Company “), a pharmaceutical company focused on developing psilocybin-based compounds ...
VANCOUVER, BC , Oct. 6, 2021 /PRNewswire/ — Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, ...
